Micron Technology (MU) 10-Q27 Jun 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	May 30, 2024	Jun. 20, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	May 30, 2024
Document Transition Report	false
Entity File Number	1-10658
Entity Registrant Name	Micron Technology, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-1618004
Entity Address, Address Line One	8000 S. Federal Way
Entity Address, City or Town	Boise
Entity Address, State or Province	ID
Entity Address, Postal Zip Code	83716
City Area Code	208
Local Phone Number	368-4000
Title of 12(b) Security	Common Stock, par value $0.10 per share
Trading Symbol	MU
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,108,841,326
Entity Central Index Key	0000723125
Current Fiscal Year End Date	--08-29
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023
Income Statement [Abstract]
Revenue	$ 6,811	$ 3,752	$ 17,361	$ 11,530
Cost of goods sold	4,979	4,420	14,485	12,511
Gross margin	1,832	(668)	2,876	(981)
Research and development	850	758	2,527	2,395
Selling, general, and administrative	291	219	834	701
Restructure and asset impairments	0	68	0	167
Other operating (income) expense, net	(28)	48	(267)	29
Operating income (loss)	719	(1,761)	(218)	(4,273)
Interest income	136	127	398	334
Interest expense	(150)	(119)	(426)	(259)
Other non-operating income (expense), net	10	0	(24)	(2)
Income (loss) before income taxes and equity in net income (loss) of equity method investees	715	(1,753)	(270)	(4,200)
Income tax (provision) benefit	(377)	(139)	172	(201)
Equity in net income (loss) of equity method investees	(6)	(4)	(11)	(2)
Net income (loss)	$ 332	$ (1,896)	$ (109)	$ (4,403)
Earnings (loss) per share
Basic (in dollars per share)	$ 0.30	$ (1.73)	$ (0.10)	$ (4.03)
Diluted (in dollars per share)	$ 0.30	$ (1.73)	$ (0.10)	$ (4.03)
Number of shares used in per share calculations
Basic (in shares)	1,107	1,094	1,104	1,092
Diluted (in shares)	1,123	1,094	1,104	1,092

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 332	$ (1,896)	$ (109)	$ (4,403)
Other comprehensive income (loss), net of tax
Gains (losses) on derivative instruments	(47)	22	(14)	222
Pension liability adjustments	(1)	(2)	(2)	(1)
Unrealized gains (losses) on investments	1	12	17	0
Foreign currency translation adjustments	0	1	0	(1)
Other comprehensive income (loss)	(47)	33	1	220
Total comprehensive income (loss)	$ 285	$ (1,863)	$ (108)	$ (4,183)

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		May 30, 2024	Aug. 31, 2023
Assets
Cash and equivalents		$ 7,594	$ 8,577
Short-term investments		785	1,017
Receivables		5,131	2,443
Inventories		8,512	8,387
Other current assets		1,297	820
Total current assets		23,319	21,244
Long-term marketable investments	[1]	775	844
Property, plant, and equipment		37,926	37,928
Operating lease right-of-use assets		660	666
Intangible assets		413	404
Deferred tax assets		597	756
Goodwill		1,150	1,150
Other noncurrent assets		1,415	1,262
Total assets		66,255	64,254
Liabilities and equity
Accounts payable and accrued expenses		5,145	3,958
Current debt		398	278
Other current liabilities		1,297	529
Total current liabilities		6,840	4,765
Long-term debt		12,860	13,052
Noncurrent operating lease liabilities		609	603
Noncurrent unearned government incentives		672	727
Other noncurrent liabilities		1,049	987
Total liabilities		22,030	20,134
Commitments and contingencies
Shareholders’ equity
Common stock, $0.10 par value, 3,000 shares authorized, 1,250 shares issued and 1,109 outstanding (1,239 shares issued and 1,098 outstanding as of August 31, 2023)		125	124
Additional capital		11,794	11,036
Retained earnings		40,169	40,824
Treasury stock, 141 shares held (141 shares as of August 31, 2023)		(7,552)	(7,552)
Accumulated other comprehensive income (loss)		(311)	(312)
Total equity		44,225	44,120
Total liabilities and equity		$ 66,255	$ 64,254

[1] The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	May 30, 2024	Aug. 31, 2023
Shareholders’ equity
Common Stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,250	1,239
Common Stock, outstanding (in shares)	1,109	1,098
Treasury Stock, held (in shares)	141	141

STATEMENT OF CHANGES IN EQUITY

STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Sep. 01, 2022		1,226
Balance of total equity at Sep. 01, 2022	$ 49,907	$ 123	$ 10,197	$ 47,274	$ (7,127)	$ (560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(195)			(195)
Other comprehensive income (loss), net	87					87
Stock issued under stock plans (in shares)		8
Stock issued under stock plans	7	$ 0	7
Stock-based compensation expense	146		146
Repurchase of stock - repurchase program	(425)				(425)
Repurchase of stock - withholdings on employee equity awards (in shares)		(2)
Repurchase of stock - withholdings on employee equity awards	$ (95)	$ 0	(15)	(80)
Dividends and dividend equivalents declared (per share)	$ 0.115
Dividends and dividend equivalents declared	$ (126)			(126)
Balance (in shares) at Dec. 01, 2022		1,232
Balance of total equity at Dec. 01, 2022	49,306	$ 123	10,335	46,873	(7,552)	(473)
Balance (in shares) at Sep. 01, 2022		1,226
Balance of total equity at Sep. 01, 2022	49,907	$ 123	10,197	47,274	(7,127)	(560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(4,403)
Other comprehensive income (loss), net	220
Balance (in shares) at Jun. 01, 2023		1,236
Balance of total equity at Jun. 01, 2023	45,405	$ 124	10,782	42,391	(7,552)	(340)
Balance (in shares) at Dec. 01, 2022		1,232
Balance of total equity at Dec. 01, 2022	49,306	$ 123	10,335	46,873	(7,552)	(473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,312)			(2,312)
Other comprehensive income (loss), net	100					100
Stock issued under stock plans (in shares)		3
Stock issued under stock plans	142	$ 0	142
Stock-based compensation expense	157		157
Repurchase of stock - withholdings on employee equity awards (in shares)		0
Repurchase of stock - withholdings on employee equity awards	$ (8)	$ 0	(1)	(7)
Dividends and dividend equivalents declared (per share)	$ 0.115
Dividends and dividend equivalents declared	$ (128)			(128)
Balance (in shares) at Mar. 02, 2023		1,235
Balance of total equity at Mar. 02, 2023	47,257	$ 123	10,633	44,426	(7,552)	(373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,896)			(1,896)
Other comprehensive income (loss), net	33					33
Stock issued under stock plans (in shares)		1
Stock issued under stock plans	7	$ 1	6
Stock-based compensation expense	145		145
Repurchase of stock - withholdings on employee equity awards (in shares)		0
Repurchase of stock - withholdings on employee equity awards	$ (13)	$ 0	(2)	(11)
Dividends and dividend equivalents declared (per share)	$ 0.115
Dividends and dividend equivalents declared	$ (128)			(128)
Balance (in shares) at Jun. 01, 2023		1,236
Balance of total equity at Jun. 01, 2023	$ 45,405	$ 124	10,782	42,391	(7,552)	(340)
Balance (in shares) at Aug. 31, 2023	1,239	1,239
Balance of total equity at Aug. 31, 2023	$ 44,120	$ 124	11,036	40,824	(7,552)	(312)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,234)			(1,234)
Other comprehensive income (loss), net	52					52
Stock issued under stock plans (in shares)		8
Stock issued under stock plans	9	$ 0	9
Stock-based compensation expense	188		188
Repurchase of stock - withholdings on employee equity awards (in shares)		(2)
Repurchase of stock - withholdings on employee equity awards	$ (121)	$ 0	(16)	(105)
Dividends and dividend equivalents declared (per share)	$ 0.115
Dividends and dividend equivalents declared	$ (129)			(129)
Balance (in shares) at Nov. 30, 2023		1,245
Balance of total equity at Nov. 30, 2023	$ 42,885	$ 124	11,217	39,356	(7,552)	(260)
Balance (in shares) at Aug. 31, 2023	1,239	1,239
Balance of total equity at Aug. 31, 2023	$ 44,120	$ 124	11,036	40,824	(7,552)	(312)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(109)
Other comprehensive income (loss), net	$ 1
Balance (in shares) at May. 30, 2024	1,250	1,250
Balance of total equity at May. 30, 2024	$ 44,225	$ 125	11,794	40,169	(7,552)	(311)
Balance (in shares) at Nov. 30, 2023		1,245
Balance of total equity at Nov. 30, 2023	42,885	$ 124	11,217	39,356	(7,552)	(260)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	793			793
Other comprehensive income (loss), net	(4)					(4)
Stock issued under stock plans (in shares)		3
Stock issued under stock plans	137	$ 1	136
Stock-based compensation expense	213		213
Repurchase of stock - withholdings on employee equity awards (in shares)		0
Repurchase of stock - withholdings on employee equity awards	$ (24)	$ 0	(2)	(22)
Dividends and dividend equivalents declared (per share)	$ 0.115
Dividends and dividend equivalents declared	$ (130)			(130)
Balance (in shares) at Feb. 29, 2024		1,248
Balance of total equity at Feb. 29, 2024	43,870	$ 125	11,564	39,997	(7,552)	(264)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	332			332
Other comprehensive income (loss), net	(47)					(47)
Stock issued under stock plans (in shares)		2
Stock issued under stock plans	14	$ 0	14
Stock-based compensation expense	219		219
Repurchase of stock - withholdings on employee equity awards (in shares)		0
Repurchase of stock - withholdings on employee equity awards	$ (33)	$ 0	(3)	(30)
Dividends and dividend equivalents declared (per share)	$ 0.115
Dividends and dividend equivalents declared	$ (130)			(130)
Balance (in shares) at May. 30, 2024	1,250	1,250
Balance of total equity at May. 30, 2024	$ 44,225	$ 125	$ 11,794	$ 40,169	$ (7,552)	$ (311)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	May 30, 2024	Jun. 01, 2023
Cash flows from operating activities
Net income (loss)	$ (109)	$ (4,403)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense and amortization of intangible assets	5,794	5,819
Stock-based compensation	620	448
Provision to write-down inventories to net realizable value	0	1,831
Change in operating assets and liabilities:
Receivables	(2,562)	2,728
Inventories	(125)	(3,406)
Other current assets	(435)	(35)
Accounts payable and accrued expenses	846	(1,113)
Other current liabilities	769	(677)
Other	304	118
Net cash provided by operating activities	5,102	1,310
Cash flows from investing activities
Expenditures for property, plant, and equipment	(5,266)	(6,215)
Purchases of available-for-sale securities	(1,110)	(496)
Proceeds from maturities and sales of available-for-sale securities	1,433	1,192
Proceeds from government incentives	267	248
Other	(35)	(90)
Net cash provided by (used for) investing activities	(4,711)	(5,361)
Cash flows from financing activities
Repayments of debt	(1,816)	(706)
Payments of dividends to shareholders	(384)	(378)
Payments on equipment purchase contracts	(127)	(112)
Repurchases of common stock - repurchase program	0	(425)
Proceeds from issuance of debt	999	6,716
Other	(40)	0
Net cash provided by (used for) financing activities	(1,368)	5,095
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	(15)	(13)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(992)	1,031
Cash, cash equivalents, and restricted cash at beginning of period	8,656	8,339
Cash, cash equivalents, and restricted cash at end of period	$ 7,664	$ 9,370

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
Significant Accounting Policies	May 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies For a discussion of our significant accounting policies, see “Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended August 31, 2023. There have been no changes to our significant accounting policies since our Annual Report on Form 10-K for the year ended August 31, 2023. Basis of Presentation The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 31, 2023. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein. Certain reclassifications have been made to prior period amounts to conform to current period presentation. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2024 and 2023 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 31, 2023.

Variable Interest Entities

Variable Interest Entities	9 Months Ended
Variable Interest Entities	May 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities A number of special purpose entities (the "Lease SPEs") were created by a third-party to facilitate equipment lease financing transactions between us and financial institutions that fund the lease financing transactions ("Financing Entities"). Neither we nor the Financing Entities have an equity interest in the Lease SPEs. The Lease SPEs are variable interest entities because their equity is not sufficient to permit them to finance their activities without additional support from the Financing Entities and because the third-party equity holder lacks characteristics of a controlling financial interest. By design, the arrangements with the Lease SPEs are merely financing vehicles and we do not bear any significant risks from variable interests with the Lease SPEs. We have determined that we do not have the power to direct the activities of the Lease SPEs that most significantly impact their economic performance and we do not consolidate the Lease SPEs. As of May 30, 2024, we had approximately $600 million of financial lease liabilities and right-of-use assets under these arrangements.

Cash and Investments

Cash and Investments	9 Months Ended
Cash and Investments	May 30, 2024
Investments and Cash [Abstract]
Cash and Investments	Cash and Investments All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: As of May 30, 2024 As of August 31, 2023 Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,355 $ — $ — $ 6,355 $ 5,771 $ — $ — $ 5,771 Level 1 (2) Money market funds 570 — — 570 1,629 — — 1,629 Level 2 (3) Certificates of deposit 554 6 — 560 1,172 25 — 1,197 Corporate bonds — 454 418 872 — 737 437 1,174 Asset-backed securities — 42 337 379 — 15 387 402 Commercial paper 56 130 — 186 — 109 — 109 Government securities 59 153 20 232 5 131 20 156 7,594 $ 785 $ 775 $ 9,154 8,577 $ 1,017 $ 844 $ 10,438 Restricted cash (4) 70 79 Cash, cash equivalents, and restricted cash $ 7,664 $ 8,656 (1) The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 30, 2024 or August 31, 2023. (4) Restricted cash is included in other current assets and other noncurrent assets and primarily relates to certain government incentives received prior to being earned and for which restrictions lapse upon achieving certain performance conditions or which will be returned if performance conditions are not met. Gross realized gains and losses from sales of available-for-sale securities were not significant for any period presented. Non-marketable Equity Investments In addition to the amounts included in the table above, we had $192 million and $218 million of non-marketable equity investments without a readily determinable fair value that were included in other noncurrent assets as of May 30, 2024 and August 31, 2023, respectively. We recognized a net loss in other non-operating income (expense) on our non-marketable investments of $29 million for the first nine months of 2024. The amounts recognized for the other periods presented were not significant. Our non-marketable equity investments are recorded at fair value on a non-recurring basis and classified as Level 3.

Receivables

Receivables	9 Months Ended
Receivables	May 30, 2024
Receivables [Abstract]
Receivables	Receivables As of May 30, August 31, Trade receivables $ 4,416 $ 2,048 Government incentives 340 105 Income and other taxes 208 194 Other 167 96 $ 5,131 $ 2,443

Inventories

Inventories	9 Months Ended
Inventories	May 30, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories As of May 30, August 31, Finished goods $ 1,280 $ 1,616 Work in process 6,542 6,111 Raw materials and supplies 690 660 $ 8,512 $ 8,387

Property, Plant, and Equipment

Property, Plant, and Equipment	9 Months Ended
Property, Plant, and Equipment	May 30, 2024
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment	Property, Plant, and Equipment As of May 30, August 31, Land $ 284 $ 283 Buildings 19,134 17,967 Equipment (1) 68,426 65,555 Construction in progress (2) 3,351 2,464 Software 1,346 1,316 92,541 87,585 Accumulated depreciation (54,615) (49,657) $ 37,926 $ 37,928 (1) Includes costs related to equipment not placed into service of $1.77 billion as of May 30, 2024 and $2.91 billion as of August 31, 2023. (2) Includes building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets

Intangible Assets	9 Months Ended
Intangible Assets	May 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets As of May 30, 2024 As of August 31, 2023 Gross Accumulated Net Carrying Amount Gross Accumulated Net Carrying Amount Product and process technology $ 662 $ (260) $ 402 $ 613 $ (209) $ 404 Other 11 — 11 — — — $ 673 $ (260) $ 413 $ 613 $ (209) $ 404 In the first nine months of 2024 and 2023, we capitalized $60 million and $72 million, respectively, for product and process technology with weighted-average useful lives of 10 years and 9 years, respectively. Amortization expense was $61 million and $66 million for the first nine months of 2024 and 2023, respectively. Expected amortization expense is $21 million for the remainder of 2024, $63 million for 2025, $53 million for 2026, $49 million for 2027, and $47 million for 2028.

Leases

Leases	9 Months Ended
Leases	May 30, 2024
Leases [Abstract]
[Finance] Leases	Leases The components of lease cost are presented below: Quarter ended Nine months ended May 30, June 1, May 30, June 1, Finance lease cost Amortization of right-of-use asset $ 52 $ 28 $ 121 $ 77 Interest on lease liability 18 6 48 18 Operating lease cost (1) 35 34 103 101 $ 105 $ 68 $ 272 $ 196 (1) Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented. Supplemental cash flow information related to leases was as follows: Nine months ended May 30, June 1, Cash flows used for operating activities Finance leases $ 41 $ 17 Operating leases 98 91 Cash flows used for financing activities – Finance leases 99 79 Noncash acquisitions of right-of-use assets Finance leases 758 354 Operating leases 48 35 Supplemental balance sheet information related to leases was as follows: As of May 30, August 31, Finance lease right-of-use assets (included in property, plant, and equipment) $ 1,944 $ 1,311 Current operating lease liabilities (included in accounts payable and accrued expenses) 68 66 Weighted-average remaining lease term (in years) Finance leases 8 9 Operating leases 10 11 Weighted-average discount rate Finance leases 4.78 % 3.86 % Operating leases 3.37 % 3.21 % As of May 30, 2024, maturities of lease liabilities by fiscal year were as follows: For the year ending Finance Leases Operating Leases Remainder of 2024 $ 95 $ 9 2025 368 86 2026 351 88 2027 341 86 2028 328 80 2029 and thereafter 778 468 Less imputed interest (335) (140) $ 1,926 $ 677 The table above excludes obligations for leases that have been executed but have not yet commenced. As of May 30, 2024, excluded obligations consisted of $704 million of finance lease obligations over a weighted-average period of 14 years for gas supply arrangements deemed to contain embedded leases and equipment leases. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use.
[Operating] Leases	Leases The components of lease cost are presented below: Quarter ended Nine months ended May 30, June 1, May 30, June 1, Finance lease cost Amortization of right-of-use asset $ 52 $ 28 $ 121 $ 77 Interest on lease liability 18 6 48 18 Operating lease cost (1) 35 34 103 101 $ 105 $ 68 $ 272 $ 196 (1) Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented. Supplemental cash flow information related to leases was as follows: Nine months ended May 30, June 1, Cash flows used for operating activities Finance leases $ 41 $ 17 Operating leases 98 91 Cash flows used for financing activities – Finance leases 99 79 Noncash acquisitions of right-of-use assets Finance leases 758 354 Operating leases 48 35 Supplemental balance sheet information related to leases was as follows: As of May 30, August 31, Finance lease right-of-use assets (included in property, plant, and equipment) $ 1,944 $ 1,311 Current operating lease liabilities (included in accounts payable and accrued expenses) 68 66 Weighted-average remaining lease term (in years) Finance leases 8 9 Operating leases 10 11 Weighted-average discount rate Finance leases 4.78 % 3.86 % Operating leases 3.37 % 3.21 % As of May 30, 2024, maturities of lease liabilities by fiscal year were as follows: For the year ending Finance Leases Operating Leases Remainder of 2024 $ 95 $ 9 2025 368 86 2026 351 88 2027 341 86 2028 328 80 2029 and thereafter 778 468 Less imputed interest (335) (140) $ 1,926 $ 677 The table above excludes obligations for leases that have been executed but have not yet commenced. As of May 30, 2024, excluded obligations consisted of $704 million of finance lease obligations over a weighted-average period of 14 years for gas supply arrangements deemed to contain embedded leases and equipment leases. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	9 Months Ended
Accounts Payable and Accrued Expenses	May 30, 2024
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	Accounts Payable and Accrued Expenses As of May 30, August 31, Accounts payable $ 1,951 $ 1,725 Property, plant, and equipment 1,663 1,419 Salaries, wages, and benefits 909 367 Income and other taxes 121 67 Other 501 380 $ 5,145 $ 3,958

Debt

Debt	9 Months Ended
Debt	May 30, 2024
Debt Disclosure [Abstract]
Debt	As of May 30, 2024 As of August 31, 2023 Net Carrying Amount Net Carrying Amount Stated Rate Effective Rate Current Long-Term Total Current Long-Term Total 2026 Term Loan A 6.791 % 6.93 % $ 49 $ 884 $ 933 $ 49 $ 921 $ 970 2027 Term Loan A 6.916 % 7.05 % 57 1,021 1,078 57 1,063 1,120 2026 Notes 4.975 % 5.07 % — 499 499 — 499 499 2027 Notes (1) 4.185 % 4.27 % — 800 800 — 798 798 2028 Notes 5.375 % 5.52 % — 597 597 — 596 596 2029 A Notes 5.327 % 5.40 % — 698 698 — 697 697 2029 B Notes 6.750 % 6.54 % — 1,262 1,262 — 1,263 1,263 2030 Notes 4.663 % 4.73 % — 847 847 — 846 846 2031 Notes 5.300 % 5.41 % — 994 994 — — — 2032 Green Bonds 2.703 % 2.77 % — 995 995 — 995 995 2033 A Notes 5.875 % 5.96 % — 745 745 — 745 745 2033 B Notes 5.875 % 6.01 % — 891 891 — 890 890 2041 Notes 3.366 % 3.41 % — 497 497 — 497 497 2051 Notes 3.477 % 3.52 % — 496 496 — 496 496 2024 Term Loan A N/A N/A — — — — 587 587 2025 Term Loan A N/A N/A — — — — 1,050 1,050 Finance lease obligations N/A 4.78 % 292 1,634 1,926 172 1,109 1,281 $ 398 $ 12,860 $ 13,258 $ 278 $ 13,052 $ 13,330 (1) In 2021, we entered into fixed-to-floating interest rate swaps on the 2027 Notes with an aggregate $900 million notional amount equal to the principal amount of the 2027 Notes. The resulting variable interest paid is at a rate equal to SOFR plus approximately 3.33%. The fixed-to-floating interest rate swaps are accounted for as fair value hedges, and as a result, the carrying values of our 2027 Notes reflect adjustments in fair value. Debt Activity The table below presents the effects of debt financing and prepayment activities in the first nine months of 2024: Transaction Date Increase (Decrease) in Principal Increase (Decrease) in Carrying Value Increase (Decrease) in Cash Issuance 2031 Notes January 12, 2024 $ 1,000 $ 993 $ 993 Prepayments 2024 Term Loan A January 12, 2024 (588) (587) (588) 2025 Term Loan A January 12, 2024 (402) (401) (402) 2025 Term Loan A May 29, 2024 (650) (649) (650) $ (640) $ (644) $ (647) 2031 Notes On January 12, 2024, we issued $1.00 billion principal amount of senior unsecured 2031 Notes in a public offering. The 2031 Notes bear interest at a rate of 5.300% per year and will mature on January 15, 2031. Issuance costs and debt discount for the 2031 Notes were $7 million. We may redeem the 2031 Notes, in whole or in part, at our option prior to their maturity dates at a redemption price equal to the greater of (i) 100% of the principal amount of the notes to be redeemed and (ii) the present value of the remaining scheduled payments of principal and interest, plus accrued interest in each case. We may also redeem the 2031 Notes, in whole or in part, at a price equal to par two months prior to maturity in accordance with the terms of the 2031 Notes. The 2031 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock and which own principal property, as defined in the indenture governing the 2031 Notes) to (1) create or incur certain liens; (2) enter into certain sale and lease-back transactions; and (3) consolidate with or merge with or into, or convey, transfer, or lease all or substantially all of our properties and assets, to another entity. These covenants are subject to a number of limitations and exceptions. Additionally, if a change of control triggering event occurs, as defined in the indenture governing the 2031 Notes, we will be required to offer to purchase the 2031 Notes at 101% of the outstanding aggregate principal amount plus accrued interest up to the purchase date. Revolving Credit Facility As of May 30, 2024, no amounts were outstanding under the Revolving Credit Facility and $2.50 billion was available to us. Under the Revolving Credit Facility, borrowings would generally bear interest at a rate equal to adjusted term SOFR plus 1.00% to 1.75%, depending on our corporate credit ratings. Adjusted term SOFR for the Revolving Credit Facility agreement is the SOFR benchmark plus a credit spread adjustment ranging from approximately 0.11% to 0.43% depending on the applicable interest period selected. Any amounts outstanding under the Revolving Credit Facility would mature in May 2026 and amounts borrowed may be prepaid without penalty. The Revolving Credit Facility requires us to maintain, on a consolidated basis, a leverage ratio of total indebtedness to adjusted EBITDA, as defined in the Revolving Credit Facility and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00. On March 27, 2023, we amended the Revolving Credit Facility to provide that in lieu of the foregoing leverage ratio, during the fourth quarter of 2023 and each quarter of 2024, we will be required to maintain, on a consolidated basis, a net leverage ratio of total net indebtedness to adjusted EBITDA, as defined in the Revolving Credit Facility and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00. Alternatively, for up to three of such five quarters, we may elect to comply with a requirement of minimum liquidity, as defined in the Revolving Credit Facility, of not less than $5.0 billion. Each of the leverage ratio and net leverage ratio maximums, as applicable, is subject to a temporary four quarter increase in such ratio to 3.75 to 1.00 following certain material acquisitions. Through the third quarter of 2024, we complied with these requirements under the Revolving Credit Facility. Maturities of Notes Payable As of May 30, 2024, maturities of notes payable by fiscal year were as follows: Remainder of 2024 $ 27 2025 107 2026 607 2027 1,780 2028 1,493 2029 and thereafter 7,450 Unamortized issuance costs, discounts, and premium, net (34) Hedge accounting fair value adjustment (98) $ 11,332

Contingencies

Contingencies	9 Months Ended
Contingencies	May 30, 2024
Loss Contingency [Abstract]
Contingencies	Contingencies We are currently a party to legal actions other than those described below arising from the normal course of business, none of which are expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. A description of certain claims is below. On April 28, 2021, Netlist, Inc. (“Netlist”) filed two patent infringement actions against Micron, Micron Semiconductor Products, Inc. (“MSP”), and Micron Technology Texas, LLC (“MTEC”) in the U.S. District Court for the Western District of Texas. The first complaint alleges that one U.S. patent is infringed by certain of our non-volatile dual in-line memory modules. The second complaint alleges that three U.S. patents are infringed by certain of our load-reduced dual in-line memory modules (“LRDIMMs”). Each complaint seeks injunctive relief, damages, attorneys’ fees, and costs. On March 31, 2022, Netlist filed a patent infringement complaint against Micron and Micron Semiconductor Germany, GmbH in Dusseldorf Regional Court alleging that two German patents are infringed by certain of our LRDIMMs. The complaint seeks damages, costs, and injunctive relief. On June 10, 2022, Netlist filed a patent infringement complaint against Micron, MSP, and MTEC in the U.S. District Court for the Eastern District of Texas (“E.D. Tex.”) alleging that six U.S. patents are infringed by certain of our memory modules and HBM products. On August 1, 2022, Netlist filed a second patent infringement complaint against the same defendants in E.D. Tex. alleging that one U.S. patent is infringed by certain of our LRDIMMs. On August 15, 2022, Netlist amended the second complaint to assert that two additional U.S. patents are infringed by certain of our LRDIMMs. The complaints in E.D. Tex. seek injunctive relief, damages, and attorneys’ fees. On May 23, 2024, following a four-day trial regarding the second complaint filed by Netlist in the E.D. Tex., a jury rendered a verdict that Micron’s memory modules infringe two asserted patents — U.S. Patent No. 7,619,912 (“the ‘912 patent”) and U.S. Patent No. 11,093,417 (“the ‘417 patent”) — and found that Micron should pay $425 million for infringement of the ‘912 patent and $20 million for infringement of the ‘417 patent. Micron expects to appeal the verdict. On April 17, 2024, the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) issued a final written decision (“FWD”) finding unpatentable the sole asserted claim of the ‘912 patent. Netlist has sought review of that ruling by the Director of the USPTO. If the Director upholds the FWD, and the United States Court of Appeals for the Federal Circuit subsequently affirms the FWD, then the affirmed FWD will preclude any pending actions asserting infringement of the ‘912 patent (including any infringement verdict that is subject to an ongoing appeal). The PTAB’s final written decision regarding whether all claims of the ‘417 patent are also unpatentable is expected to be issued on or before August 2, 2024. On August 16, 2022, Sonrai Memory Ltd. filed a patent infringement complaint against Micron in the U.S. District Court for the Western District of Texas. The complaint alleges that two U.S. patents are infringed by certain SSD and NAND flash products. The complaint seeks damages, attorneys’ fees, and costs. On January 23, 2023, Besang Inc. filed a patent infringement complaint against Micron in the U.S. District Court for the Eastern District of Texas. The complaint alleges that one U.S. patent is infringed by certain of our 3D NAND and SSD products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On November 9, 2023, Yangtze Memory Technologies Company, Ltd. (“YMTC”) filed a patent infringement complaint against Micron and one of its subsidiaries in the U.S. District Court for the Northern District of California. The complaint alleges that eight U.S. patents are infringed by certain of our 3D NAND products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On January 22, 2024, Micron Semiconductor (Shanghai) Co., Ltd. (“MSS”) was served with three patent infringement complaints filed by YMTC in Beijing Intellectual Property Court and on February 27, 2024, Micron Technology, Inc. (“MTI”) was served with the same complaints. The complaints assert that MTI and MSS infringed three Chinese patents owned by YMTC by importing, selling, offering for sale, and assisting others to sell certain 3D NAND products and SSDs in China. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On June 3, 2024, MimirIP LLC (“MimirIP”) submitted a complaint to the United States International Trade Commission (“ITC”) alleging that certain of Micron’s DRAM and NAND products infringe six patents owned by MimirIP. The complaint requests the ITC to institute an investigation of such alleged infringement pursuant to Section 337 of the Tariff Act of 1930 and to issue a permanent limited exclusion order barring from entry into the United States such allegedly infringing DRAM and NAND devices and electronic devices containing the same produced by several alleged customers of Micron. On June 3, 2024, MimirIP filed a complaint against Micron, two of its subsidiaries, and certain alleged customers of Micron in the E.D. Tex. alleging that the same six patents as are asserted in the ITC are infringed by certain of Micron’s DRAM and NAND products. The complaint seeks damages, attorneys’ fees, and costs. On June 4, 2024, MimirIP filed a second complaint against Micron, two of its subsidiaries, and certain alleged customers of Micron in the E.D. Tex. alleging that six additional patents are infringed by certain of Micron’s DRAM and NAND products. The complaint seeks damages, attorneys’ fees, and costs. The above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for substantially all of our revenue. Antitrust Matters On May 15, 2018, the Chinese State Administration for Market Regulation (“SAMR”) notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation. Other Matters In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify another party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition. Contingency Assessment We ar e unable to predict the outcome of any of the matters noted above and cannot make a reasonable estimate of the potential loss or range of possible losses. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.

Equity

Equity	9 Months Ended
Equity	May 30, 2024
Equity [Abstract]
Equity	Equity Common Stock Repurchases In May 2018, our Board of Directors authorized the discretionary repurchase of up to $10 billion of our outstanding common stock through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans. The repurchase authorization has no expiration date, does not obligate us to acquire any common stock, and is subject to market conditions and our ongoing determination of the best use of available cash. No shares were repurchased under this authorization in the first nine months of 2024. Through May 30, 2024, we had repurchased an aggregate of $6.89 billion under the authorization. Amounts repurchased are included in treasury stock. Dividends We paid dividends of $128 million ($0.115 per share), $127 million ($0.115 per share), and $129 million ($0.115 per share) in the third, second, and first quarters of 2024, respectively. On June 26, 2024, our Board of Directors declared a quarterly dividend of $0.115 per share, payable in cash on July 23, 2024, to shareholders of record as of the close of business on July 8, 2024. Accumulated Other Comprehensive Income (Loss) Changes in accumulated other comprehensive income (loss) by component for the nine months ended May 30, 2024 were as follows: Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Pension Liability Adjustments Cumulative Foreign Currency Translation Adjustment Total As of August 31, 2023 $ (304) $ (41) $ 36 $ (3) $ (312) Other comprehensive income (loss) before reclassifications (151) 16 — — (135) Amount reclassified out of accumulated other comprehensive income (loss) 139 — (3) — 136 Tax effects (2) 1 1 — — Other comprehensive income (loss) (14) 17 (2) — 1 As of May 30, 2024 $ (318) $ (24) $ 34 $ (3) $ (311)

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	May 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The estimated fair values and carrying values of our outstanding debt instruments were as follows: As of May 30, 2024 As of August 31, 2023 Fair Carrying Fair Carrying Notes $ 11,037 $ 11,332 $ 11,549 $ 12,049 The fair values of our debt instruments were estimated based on Level 2 inputs, including the trading price of our notes when available, discounted cash flows, and interest rates based on similar debt issued by parties with credit ratings similar to ours.

Derivative Instruments

Derivative Instruments	9 Months Ended
Derivative Instruments	May 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Notional or Contractual Amount Fair Value of Assets (1) Liabilities (2) As of May 30, 2024 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 4,177 $ 2 $ (234) Cash flow commodity hedges 458 25 (4) Fair value interest rate hedges 900 — (98) Derivative instruments without hedge accounting designation Non-designated currency hedges 1,964 4 (12) $ 31 $ (348) As of August 31, 2023 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 3,873 $ 16 $ (180) Cash flow commodity hedges 331 45 — Fair value interest rate hedges 900 — (100) Derivative instruments without hedge accounting designation Non-designated currency hedges 1,839 2 (17) $ 63 $ (297) (1) Included in receivables and other noncurrent assets. (2) Included in accounts payable and accrued expenses and other noncurrent liabilities. Derivative Instruments with Hedge Accounting Designation Cash Flow Hedges : We utilize forward and swap contracts that generally mature within two years designated as cash flow hedges to minimize our exposure to changes in currency exchange rates or commodity prices for certain capital expenditures and manufacturing costs. Forward and swap contracts are measured at fair value based on market-based observable inputs including market spot and forward rates, interest rates, and credit-risk spreads (Level 2). The effects of cash flow hedging activities were as follows: Quarter ended Nine months ended May 30, June 1, May 30, June 1, Gain (loss) from cash flow hedges in accumulated other comprehensive income (loss) $ (99) $ (40) $ (142) $ 88 Gain (loss) excluded from effectiveness testing in cost of goods sold (35) (26) (105) (71) Gain (loss) reclassified from accumulated other comprehensive income (loss) to earnings, primarily to cost of goods sold (39) (77) (139) (199) As of May 30, 2024, we expect to reclassify $168 million of pre-tax losses related to cash flow hedges from accumulated other comprehensive income (loss) into earnings in the next 12 months. Fair Value Hedges : We utilize fixed-to-floating interest rate swaps designated as fair value hedges to minimize certain exposures to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. Interest rate swaps are measured at fair value based on market-based observable inputs including interest rates and credit-risk spreads (Level 2). The changes in the fair values of derivatives designated as fair value hedges and the offsetting changes in the underlying fair values of the hedged items are both recognized in earnings. When a derivative is no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured or been extinguished. The effects of fair value hedges on our consolidated statements of operations, recognized in interest expense, were not significant for the periods presented. Derivative Instruments without Hedge Accounting Designation Currency Derivatives : We generally utilize a rolling hedge strategy with currency forward contracts that mature within three months to hedge our exposures of monetary assets and liabilities from changes in currency exchange rates. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2). Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the changes in the underlying monetary assets and liabilities from changes in currency exchange rates are included in other non-operating income (expense), net. The amounts recognized for derivative instruments without hedge accounting designation were not significant for the periods presented. We do not use derivative instruments for speculative purposes.

Equity Plans

Equity Plans	9 Months Ended
Equity Plans	May 30, 2024
Share-Based Payment Arrangement [Abstract]
Equity Plans	Equity Plans As of May 30, 2024, 72 million shares of our common stock were available for future awards under our equity plans, including 12 million shares approved for issuance under our employee stock purchase plan (“ESPP”). Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”) Restricted Stock Awards activity is summarized as follows: Nine months ended May 30, June 1, Restricted stock award shares granted 12 14 Weighted-average grant-date fair value per share $ 69.02 $ 54.13 Employee Stock Purchase Plan (“ESPP”) For each six Stock-based Compensation Expense Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $100 million and $88 million was capitalized and remained in inventory as of May 30, 2024 and August 31, 2023, respectively. Quarter ended Nine months ended May 30, June 1, May 30, June 1, Stock-based compensation expense by caption Cost of goods sold $ 80 $ 61 $ 227 $ 137 Research and development 77 57 222 169 Selling, general, and administrative 60 34 159 107 Restructure — (4) — (6) $ 217 $ 148 $ 608 $ 407 Stock-based compensation expense by type of award Restricted stock awards $ 201 $ 129 $ 555 $ 354 ESPP 16 19 53 53 $ 217 $ 148 $ 608 $ 407 As of May 30, 2024, $1.51 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the third quarter of 2028, resulting in a weighted-average period of 1.3 years.

Revenue and Customer Contract L

Revenue and Customer Contract Liabilities	9 Months Ended
Revenue and Customer Contract Liabilities	May 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue and Customer Contract Liabilities	Revenue and Customer Contract Liabilities Revenue by Technology Quarter ended Nine months ended May 30, June 1, May 30, June 1, DRAM $ 4,692 $ 2,672 $ 12,277 $ 8,223 NAND 2,065 1,013 4,862 3,001 Other (primarily NOR) 54 67 222 306 $ 6,811 $ 3,752 $ 17,361 $ 11,530 See “Segment and Other Information” for disclosure of disaggregated revenue by market segment. Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Substantially all contracts with our customers are short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year. As of May 30, 2024, our future performance obligations beyond one year were $141 million, which included customer prepayments and other contract liabilities. Customer prepayments made to secure product supply in future periods and other contract liabilities were $756 million as of May 30, 2024, of which $615 million was reported in other current liabilities and the remainder in other noncurrent liabilities. As of May 30, 2024 and August 31, 2023, other current liabilities also included $617 million and $453 million, respectively, for estimates of consideration payable to customers including estimates for pricing adjustments and returns.

Restructure and Asset Impairmen

Restructure and Asset Impairments	9 Months Ended
Restructure and Asset Impairments	May 30, 2024
Restructuring and Related Activities [Abstract]
Restructure and Asset Impairments	Restructure and Asset Impairments Quarter ended Nine months ended May 30, June 1, May 30, June 1, Employee severance $ — $ 70 $ — $ 163 Asset impairments and other asset-related costs — 1 — 9 Other — (3) — (5) $ — $ 68 $ — $ 167 In 2023, we initiated a restructure plan in response to challenging industry conditions (the “2023 Restructure Plan”). Under the 2023 Restructure Plan, we reduced our headcount by approximately 15% by the end of calendar 2023, through a combination of voluntary attrition and personnel reductions. The plan was substantially completed in 2023.

Other Operating (Income) Expens

Other Operating (Income) Expense, Net	9 Months Ended
Other Operating (Income) Expense, Net	May 30, 2024
Other Income and Expenses [Abstract]
Other Operating (Income) Expense, Net	Other Operating (Income) Expense, Net Quarter ended Nine months ended May 30, June 1, May 30, June 1, (Gain) loss on disposition of property, plant, and equipment $ (38) $ (24) $ (63) $ (46) Patent cross-license agreement gain — — (200) — Litigation settlement — 68 — 68 Other 10 4 (4) 7 $ (28) $ 48 $ (267) $ 29

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	May 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our income tax (provision) benefit consisted of the following: Quarter ended Nine months ended May 30, June 1, May 30, June 1, Income (loss) before taxes $ 715 $ (1,753) $ (270) $ (4,200) Income tax (provision) benefit (377) (139) 172 (201) Effective tax rate 52.7 % (7.9) % 63.7 % (4.8) % In the first quarter of 2024, our tax expense was based on actual results for jurisdictions where small changes in our projected pre-tax income would have caused significant changes in the estimated annual effective tax rate. With our improved fiscal 2024 outlook, we were able to estimate a more reliable annual effective tax rate and have reverted to a global annual effective tax rate method for all jurisdictions beginning in the second quarter of 2024. The changes in our effective tax rate for the third quarter and first nine months of 2024 as compared to the third quarter and first nine months of 2023 were primarily due to changes in profitability and discrete items primarily related to tax return filings. We operate in a number of jurisdictions outside the United States, including Singapore, where we have tax incentive arrangements. These incentives expire, in whole or in part, at various dates through 2034 and are conditional, in part, upon meeting certain business operations and employment thresholds. As a result of the low level of profitability and the geographic mix of income, the benefit from tax incentive arrangements was not material for the periods presented. As of May 30, 2024, other current assets included $539 million related to income taxes.

Earnings Per Share

Earnings Per Share	9 Months Ended
Earnings Per Share	May 30, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Quarter ended Nine months ended May 30, June 1, May 30, June 1, Net income (loss) – Basic and Diluted $ 332 $ (1,896) $ (109) $ (4,403) Weighted-average common shares outstanding – Basic 1,107 1,094 1,104 1,092 Dilutive effect of equity plans 16 — — — Weighted-average common shares outstanding – Diluted 1,123 1,094 1,104 1,092 Earnings (loss) per share Basic $ 0.30 $ (1.73) $ (0.10) $ (4.03) Diluted 0.30 (1.73) (0.10) (4.03) Antidilutive potential common shares excluded from the computation of diluted earnings per share, that could dilute basic earnings per share in the future, were 1 million and 31 million for the third quarter and first nine months of 2024, respectively, and were 31 million and 33 million for the third quarter and first nine months of 2023, respectively.

Segment and Other Information

Segment and Other Information	9 Months Ended
Segment and Other Information	May 30, 2024
Segment Reporting [Abstract]
Segment and Other Information	Segment and Other Information Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments: Compute and Networking Business Unit (“CNBU”) : Includes memory products and solutions sold into the client, cloud server, enterprise, graphics, and networking markets. Mobile Business Unit (“MBU”) : Includes memory and storage products sold into the smartphone and other mobile-device markets. Embedded Business Unit (“EBU”) : Includes memory and storage products and solutions sold into the automotive, industrial, and consumer markets. Storage Business Unit (“SBU”) : Includes SSDs and component-level solutions sold into the enterprise and cloud, client, and consumer storage markets. Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments. Quarter ended Nine months ended May 30, June 1, May 30, June 1, Revenue CNBU $ 2,573 $ 1,389 $ 6,495 $ 4,510 MBU 1,588 819 4,479 2,419 EBU 1,294 912 3,442 2,777 SBU 1,353 627 2,911 1,814 All Other 3 5 34 10 $ 6,811 $ 3,752 $ 17,361 $ 11,530 Operating income (loss) CNBU $ 442 $ (337) $ 73 $ (182) MBU 301 (478) (395) (1,017) EBU 124 65 133 347 SBU 76 (601) (631) (1,215) All Other (2) 2 23 6 941 (1,349) (797) (2,061) Unallocated Stock-based compensation (217) (151) (608) (413) Restructure and asset impairments — (68) — (167) Provision to write-down inventories to net realizable value — (401) — (1,831) Lower costs from sale of inventory written down in prior periods — 281 987 281 Patent cross-license agreement gain — — 200 — Litigation settlement — (68) — (68) Other (5) (5) — (14) (222) (412) 579 (2,212) Operating income (loss) $ 719 $ (1,761) $ (218) $ (4,273)

Certain Concentrations

Certain Concentrations	9 Months Ended
Certain Concentrations	May 30, 2024
Risks and Uncertainties [Abstract]
Certain Concentrations	Certain Concentrations Revenue by end market as an approximate percentage of total revenue is presented in the table below: Nine months ended May 30, June 1, Mobile 25 % 20 % Automotive, industrial, and consumer 20 % 25 % Enterprise and cloud server 20 % 20 % Client and graphics 15 % 20 % SSDs and other storage 15 % 15 % Revenue from one customer, which is a distributor, was 11% of total revenue for the first nine months of 2024. No customer accounted for 10% or more of total revenue for the first nine months of 2023.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	May 30, 2024	Feb. 29, 2024	Nov. 30, 2023	Jun. 01, 2023	Mar. 02, 2023	Dec. 01, 2022	May 30, 2024	Jun. 01, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 332	$ 793	$ (1,234)	$ (1,896)	$ (2,312)	$ (195)	$ (109)	$ (4,403)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	May 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	May 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 31, 2023.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation.
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2024 and 2023 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated.

Segment Reporting (Policies)

Segment Reporting (Policies)	9 Months Ended
Segment Reporting (Policies)	May 30, 2024
Segment Reporting [Abstract]
Segment Reporting Policy	Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.

Cash and Investments (Tables)

Cash and Investments (Tables)	9 Months Ended
Cash and Investments (Tables)	May 30, 2024
Investments and Cash [Abstract]
Cash and Investments	All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: As of May 30, 2024 As of August 31, 2023 Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,355 $ — $ — $ 6,355 $ 5,771 $ — $ — $ 5,771 Level 1 (2) Money market funds 570 — — 570 1,629 — — 1,629 Level 2 (3) Certificates of deposit 554 6 — 560 1,172 25 — 1,197 Corporate bonds — 454 418 872 — 737 437 1,174 Asset-backed securities — 42 337 379 — 15 387 402 Commercial paper 56 130 — 186 — 109 — 109 Government securities 59 153 20 232 5 131 20 156 7,594 $ 785 $ 775 $ 9,154 8,577 $ 1,017 $ 844 $ 10,438 Restricted cash (4) 70 79 Cash, cash equivalents, and restricted cash $ 7,664 $ 8,656 (1) The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 30, 2024 or August 31, 2023. (4)
Cash and equivalents and the fair values of available-for-sale investments	All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: As of May 30, 2024 As of August 31, 2023 Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,355 $ — $ — $ 6,355 $ 5,771 $ — $ — $ 5,771 Level 1 (2) Money market funds 570 — — 570 1,629 — — 1,629 Level 2 (3) Certificates of deposit 554 6 — 560 1,172 25 — 1,197 Corporate bonds — 454 418 872 — 737 437 1,174 Asset-backed securities — 42 337 379 — 15 387 402 Commercial paper 56 130 — 186 — 109 — 109 Government securities 59 153 20 232 5 131 20 156 7,594 $ 785 $ 775 $ 9,154 8,577 $ 1,017 $ 844 $ 10,438 Restricted cash (4) 70 79 Cash, cash equivalents, and restricted cash $ 7,664 $ 8,656 (1) The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 30, 2024 or August 31, 2023. (4)

Receivables (Tables)

Receivables (Tables)	9 Months Ended
Receivables (Tables)	May 30, 2024
Receivables [Abstract]
Schedule of Receivables	As of May 30, August 31, Trade receivables $ 4,416 $ 2,048 Government incentives 340 105 Income and other taxes 208 194 Other 167 96 $ 5,131 $ 2,443

Inventories (Tables)

Inventories (Tables)	9 Months Ended
Inventories (Tables)	May 30, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	As of May 30, August 31, Finished goods $ 1,280 $ 1,616 Work in process 6,542 6,111 Raw materials and supplies 690 660 $ 8,512 $ 8,387

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	9 Months Ended
Property, Plant, and Equipment (Tables)	May 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant, and Equipment	As of May 30, August 31, Land $ 284 $ 283 Buildings 19,134 17,967 Equipment (1) 68,426 65,555 Construction in progress (2) 3,351 2,464 Software 1,346 1,316 92,541 87,585 Accumulated depreciation (54,615) (49,657) $ 37,926 $ 37,928 (1) Includes costs related to equipment not placed into service of $1.77 billion as of May 30, 2024 and $2.91 billion as of August 31, 2023. (2) Includes building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
Intangible Assets (Tables)	May 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	As of May 30, 2024 As of August 31, 2023 Gross Accumulated Net Carrying Amount Gross Accumulated Net Carrying Amount Product and process technology $ 662 $ (260) $ 402 $ 613 $ (209) $ 404 Other 11 — 11 — — — $ 673 $ (260) $ 413 $ 613 $ (209) $ 404

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	May 30, 2024
Leases [Abstract]
Schedule of Components of Lease Expense	Quarter ended Nine months ended May 30, June 1, May 30, June 1, Finance lease cost Amortization of right-of-use asset $ 52 $ 28 $ 121 $ 77 Interest on lease liability 18 6 48 18 Operating lease cost (1) 35 34 103 101 $ 105 $ 68 $ 272 $ 196
Schedule of Other Lease Information	Supplemental cash flow information related to leases was as follows: Nine months ended May 30, June 1, Cash flows used for operating activities Finance leases $ 41 $ 17 Operating leases 98 91 Cash flows used for financing activities – Finance leases 99 79 Noncash acquisitions of right-of-use assets Finance leases 758 354 Operating leases 48 35 Supplemental balance sheet information related to leases was as follows: As of May 30, August 31, Finance lease right-of-use assets (included in property, plant, and equipment) $ 1,944 $ 1,311 Current operating lease liabilities (included in accounts payable and accrued expenses) 68 66 Weighted-average remaining lease term (in years) Finance leases 8 9 Operating leases 10 11 Weighted-average discount rate Finance leases 4.78 % 3.86 % Operating leases 3.37 % 3.21 %
Schedule of Finance Lease Maturities	For the year ending Finance Leases Operating Leases Remainder of 2024 $ 95 $ 9 2025 368 86 2026 351 88 2027 341 86 2028 328 80 2029 and thereafter 778 468 Less imputed interest (335) (140) $ 1,926 $ 677
Schedule of Operating Lease Maturities	For the year ending Finance Leases Operating Leases Remainder of 2024 $ 95 $ 9 2025 368 86 2026 351 88 2027 341 86 2028 328 80 2029 and thereafter 778 468 Less imputed interest (335) (140) $ 1,926 $ 677

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	9 Months Ended
Accounts Payable and Accrued Expenses (Tables)	May 30, 2024
Payables and Accruals [Abstract]
Schedule of Accounts Payable And Accrued Expenses	As of May 30, August 31, Accounts payable $ 1,951 $ 1,725 Property, plant, and equipment 1,663 1,419 Salaries, wages, and benefits 909 367 Income and other taxes 121 67 Other 501 380 $ 5,145 $ 3,958

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	May 30, 2024
Debt Disclosure [Abstract]
Schedule of Debt	As of May 30, 2024 As of August 31, 2023 Net Carrying Amount Net Carrying Amount Stated Rate Effective Rate Current Long-Term Total Current Long-Term Total 2026 Term Loan A 6.791 % 6.93 % $ 49 $ 884 $ 933 $ 49 $ 921 $ 970 2027 Term Loan A 6.916 % 7.05 % 57 1,021 1,078 57 1,063 1,120 2026 Notes 4.975 % 5.07 % — 499 499 — 499 499 2027 Notes (1) 4.185 % 4.27 % — 800 800 — 798 798 2028 Notes 5.375 % 5.52 % — 597 597 — 596 596 2029 A Notes 5.327 % 5.40 % — 698 698 — 697 697 2029 B Notes 6.750 % 6.54 % — 1,262 1,262 — 1,263 1,263 2030 Notes 4.663 % 4.73 % — 847 847 — 846 846 2031 Notes 5.300 % 5.41 % — 994 994 — — — 2032 Green Bonds 2.703 % 2.77 % — 995 995 — 995 995 2033 A Notes 5.875 % 5.96 % — 745 745 — 745 745 2033 B Notes 5.875 % 6.01 % — 891 891 — 890 890 2041 Notes 3.366 % 3.41 % — 497 497 — 497 497 2051 Notes 3.477 % 3.52 % — 496 496 — 496 496 2024 Term Loan A N/A N/A — — — — 587 587 2025 Term Loan A N/A N/A — — — — 1,050 1,050 Finance lease obligations N/A 4.78 % 292 1,634 1,926 172 1,109 1,281 $ 398 $ 12,860 $ 13,258 $ 278 $ 13,052 $ 13,330 (1)
Schedule of Debt Activity	Transaction Date Increase (Decrease) in Principal Increase (Decrease) in Carrying Value Increase (Decrease) in Cash Issuance 2031 Notes January 12, 2024 $ 1,000 $ 993 $ 993 Prepayments 2024 Term Loan A January 12, 2024 (588) (587) (588) 2025 Term Loan A January 12, 2024 (402) (401) (402) 2025 Term Loan A May 29, 2024 (650) (649) (650) $ (640) $ (644) $ (647)
Schedule of Maturities of Notes Payable	As of May 30, 2024, maturities of notes payable by fiscal year were as follows: Remainder of 2024 $ 27 2025 107 2026 607 2027 1,780 2028 1,493 2029 and thereafter 7,450 Unamortized issuance costs, discounts, and premium, net (34) Hedge accounting fair value adjustment (98) $ 11,332

Equity (Tables)

Equity (Tables)	9 Months Ended
Equity (Tables)	May 30, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Pension Liability Adjustments Cumulative Foreign Currency Translation Adjustment Total As of August 31, 2023 $ (304) $ (41) $ 36 $ (3) $ (312) Other comprehensive income (loss) before reclassifications (151) 16 — — (135) Amount reclassified out of accumulated other comprehensive income (loss) 139 — (3) — 136 Tax effects (2) 1 1 — — Other comprehensive income (loss) (14) 17 (2) — 1 As of May 30, 2024 $ (318) $ (24) $ 34 $ (3) $ (311)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	May 30, 2024
Fair Value Disclosures [Abstract]
Estimated Fair Value and Carrying Value of Debt Instruments	As of May 30, 2024 As of August 31, 2023 Fair Carrying Fair Carrying Notes $ 11,037 $ 11,332 $ 11,549 $ 12,049

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
Derivative Instruments (Tables)	May 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	Notional or Contractual Amount Fair Value of Assets (1) Liabilities (2) As of May 30, 2024 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 4,177 $ 2 $ (234) Cash flow commodity hedges 458 25 (4) Fair value interest rate hedges 900 — (98) Derivative instruments without hedge accounting designation Non-designated currency hedges 1,964 4 (12) $ 31 $ (348) As of August 31, 2023 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 3,873 $ 16 $ (180) Cash flow commodity hedges 331 45 — Fair value interest rate hedges 900 — (100) Derivative instruments without hedge accounting designation Non-designated currency hedges 1,839 2 (17) $ 63 $ (297) (1) Included in receivables and other noncurrent assets. (2) Included in accounts payable and accrued expenses and other noncurrent liabilities.
Schedule of Gains and Losses on Derivative Instruments	Quarter ended Nine months ended May 30, June 1, May 30, June 1, Gain (loss) from cash flow hedges in accumulated other comprehensive income (loss) $ (99) $ (40) $ (142) $ 88 Gain (loss) excluded from effectiveness testing in cost of goods sold (35) (26) (105) (71) Gain (loss) reclassified from accumulated other comprehensive income (loss) to earnings, primarily to cost of goods sold (39) (77) (139) (199)

Equity Plans (Tables)

Equity Plans (Tables)	9 Months Ended
Equity Plans (Tables)	May 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Restricted Stock Awards Activity	Nine months ended May 30, June 1, Restricted stock award shares granted 12 14 Weighted-average grant-date fair value per share $ 69.02 $ 54.13
Schedule of Stock-based Compensation Expense	Quarter ended Nine months ended May 30, June 1, May 30, June 1, Stock-based compensation expense by caption Cost of goods sold $ 80 $ 61 $ 227 $ 137 Research and development 77 57 222 169 Selling, general, and administrative 60 34 159 107 Restructure — (4) — (6) $ 217 $ 148 $ 608 $ 407 Stock-based compensation expense by type of award Restricted stock awards $ 201 $ 129 $ 555 $ 354 ESPP 16 19 53 53 $ 217 $ 148 $ 608 $ 407

Revenue and Customer Contract_2

Revenue and Customer Contract Liabilities (Tables)	9 Months Ended
Revenue and Customer Contract Liabilities (Tables)	May 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Technology	Quarter ended Nine months ended May 30, June 1, May 30, June 1, DRAM $ 4,692 $ 2,672 $ 12,277 $ 8,223 NAND 2,065 1,013 4,862 3,001 Other (primarily NOR) 54 67 222 306 $ 6,811 $ 3,752 $ 17,361 $ 11,530

Restructure and Asset Impairm_2

Restructure and Asset Impairments (Tables)	9 Months Ended
Restructure and Asset Impairments (Tables)	May 30, 2024
Restructuring and Related Activities [Abstract]
Restructure and Asset Impairments	Quarter ended Nine months ended May 30, June 1, May 30, June 1, Employee severance $ — $ 70 $ — $ 163 Asset impairments and other asset-related costs — 1 — 9 Other — (3) — (5) $ — $ 68 $ — $ 167

Other Operating (Income) Expe_2

Other Operating (Income) Expense, Net (Tables)	9 Months Ended
Other Operating (Income) Expense, Net (Tables)	May 30, 2024
Other Income and Expenses [Abstract]
Schedule of Other Operating (Income) Expense, Net	Quarter ended Nine months ended May 30, June 1, May 30, June 1, (Gain) loss on disposition of property, plant, and equipment $ (38) $ (24) $ (63) $ (46) Patent cross-license agreement gain — — (200) — Litigation settlement — 68 — 68 Other 10 4 (4) 7 $ (28) $ 48 $ (267) $ 29

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
Income Taxes (Tables)	May 30, 2024
Income Tax Disclosure [Abstract]
Schedule of Income Tax (Provision) Benefit	Our income tax (provision) benefit consisted of the following: Quarter ended Nine months ended May 30, June 1, May 30, June 1, Income (loss) before taxes $ 715 $ (1,753) $ (270) $ (4,200) Income tax (provision) benefit (377) (139) 172 (201) Effective tax rate 52.7 % (7.9) % 63.7 % (4.8) %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
Earnings Per Share (Tables)	May 30, 2024
Earnings Per Share [Abstract]
Basic and Diluted Earnings Per Share	Quarter ended Nine months ended May 30, June 1, May 30, June 1, Net income (loss) – Basic and Diluted $ 332 $ (1,896) $ (109) $ (4,403) Weighted-average common shares outstanding – Basic 1,107 1,094 1,104 1,092 Dilutive effect of equity plans 16 — — — Weighted-average common shares outstanding – Diluted 1,123 1,094 1,104 1,092 Earnings (loss) per share Basic $ 0.30 $ (1.73) $ (0.10) $ (4.03) Diluted 0.30 (1.73) (0.10) (4.03)

Segment and Other Information (

Segment and Other Information (Tables)	9 Months Ended
Segment and Other Information (Tables)	May 30, 2024
Segment Reporting [Abstract]
Schedule of Results by Segment	Quarter ended Nine months ended May 30, June 1, May 30, June 1, Revenue CNBU $ 2,573 $ 1,389 $ 6,495 $ 4,510 MBU 1,588 819 4,479 2,419 EBU 1,294 912 3,442 2,777 SBU 1,353 627 2,911 1,814 All Other 3 5 34 10 $ 6,811 $ 3,752 $ 17,361 $ 11,530 Operating income (loss) CNBU $ 442 $ (337) $ 73 $ (182) MBU 301 (478) (395) (1,017) EBU 124 65 133 347 SBU 76 (601) (631) (1,215) All Other (2) 2 23 6 941 (1,349) (797) (2,061) Unallocated Stock-based compensation (217) (151) (608) (413) Restructure and asset impairments — (68) — (167) Provision to write-down inventories to net realizable value — (401) — (1,831) Lower costs from sale of inventory written down in prior periods — 281 987 281 Patent cross-license agreement gain — — 200 — Litigation settlement — (68) — (68) Other (5) (5) — (14) (222) (412) 579 (2,212) Operating income (loss) $ 719 $ (1,761) $ (218) $ (4,273)

Certain Concentrations (Tables)

Certain Concentrations (Tables)	9 Months Ended
Certain Concentrations (Tables)	May 30, 2024
Risks and Uncertainties [Abstract]
Schedule of Market Concentration Risk	Nine months ended May 30, June 1, Mobile 25 % 20 % Automotive, industrial, and consumer 20 % 25 % Enterprise and cloud server 20 % 20 % Client and graphics 15 % 20 % SSDs and other storage 15 % 15 %

Variable Interest Entities (Det

Variable Interest Entities (Details) - USD ($) $ in Millions	May 30, 2024	Aug. 31, 2023
Variable Interest Entity [Line Items]
Finance Lease Liability	$ 1,926	$ 1,281
Finance Lease Right-of-Use Assets	1,944	$ 1,311
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Finance Lease Liability	600
Finance Lease Right-of-Use Assets	$ 600

Cash and Investments (Details)

Cash and Investments (Details) - USD ($) $ in Millions		May 30, 2024	Aug. 31, 2023	Jun. 01, 2023	Sep. 01, 2022
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents		$ 7,594	$ 8,577
Short-term Investments		785	1,017
Long-term Marketable Investments	[1]	775	844
Total Fair Value		9,154	10,438
Restricted cash	[2]	70	79
Cash, cash equivalents, and restricted cash		$ 7,664	8,656	$ 9,370	$ 8,339
Minimum
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Term, Noncurrent		1 year
Maximum
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Term, Noncurrent		5 years
Cash
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents		$ 6,355	5,771
Short-term Investments		0	0
Long-term Marketable Investments		0	0
Total Fair Value		6,355	5,771
Money market funds \| Level 1
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[3]	570	1,629
Short-term Investments	[3]	0	0
Long-term Marketable Investments	[1],[3]	0	0
Total Fair Value	[3]	570	1,629
Certificates of deposit \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	554	1,172
Short-term Investments	[4]	6	25
Long-term Marketable Investments	[1],[4]	0	0
Total Fair Value	[4]	560	1,197
Corporate bonds \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	0	0
Short-term Investments	[4]	454	737
Long-term Marketable Investments	[1],[4]	418	437
Total Fair Value	[4]	872	1,174
Asset-backed securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	0	0
Short-term Investments	[4]	42	15
Long-term Marketable Investments	[1],[4]	337	387
Total Fair Value	[4]	379	402
Commercial paper \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	56	0
Short-term Investments	[4]	130	109
Long-term Marketable Investments	[1],[4]	0	0
Total Fair Value	[4]	186	109
Government securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	59	5
Short-term Investments	[4]	153	131
Long-term Marketable Investments	[1],[4]	20	20
Total Fair Value	[4]	$ 232	$ 156

[1] The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date. Restricted cash is included in other current assets and other noncurrent assets and primarily relates to certain government incentives received prior to being earned and for which restrictions lapse upon achieving certain performance conditions or which will be returned if performance conditions are not met. The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 30, 2024 or August 31, 2023.

Cash and Investments - Non-mark

Cash and Investments - Non-marketable Equity Investments (Details) - USD ($) $ in Millions	9 Months Ended
	May 30, 2024	Aug. 31, 2023
Equity Securities without Readily Determinable Fair Value [Line Items]
Equity Securities without Readily Determinable Fair Value, Impairment Loss	$ 29
Fair Value, Inputs, Level 3
Equity Securities without Readily Determinable Fair Value [Line Items]
Equity Securities without Readily Determinable Fair Value	$ 192	$ 218

Receivables (Details)

Receivables (Details) - USD ($) $ in Millions	May 30, 2024	Aug. 31, 2023
Receivables [Abstract]
Trade receivables	$ 4,416	$ 2,048
Government incentives	340	105
Income and other taxes	208	194
Other	167	96
Receivables	$ 5,131	$ 2,443

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	May 30, 2024	Aug. 31, 2023
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 1,280	$ 1,616
Work in process	6,542	6,111
Raw materials and supplies	690	660
Inventories	$ 8,512	$ 8,387

Property, Plant, and Equipmen_2

Property, Plant, and Equipment (Details) - USD ($) $ in Millions		May 30, 2024	Aug. 31, 2023
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		$ 92,541	$ 87,585
Accumulated depreciation		(54,615)	(49,657)
Property, plant, and equipment, net		37,926	37,928
Land
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		284	283
Buildings
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		19,134	17,967
Equipment
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross	[1]	68,426	65,555
Equipment not placed into service
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		1,770	2,910
Construction in progress
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross	[2]	3,351	2,464
Software
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		$ 1,346	$ 1,316

[1] Includes costs related to equipment not placed into service of $1.77 billion as of May 30, 2024 and $2.91 billion as of August 31, 2023. Includes building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Millions	9 Months Ended
Intangible Assets (Details) - USD ($) $ in Millions	May 30, 2024	Jun. 01, 2023	Aug. 31, 2023
Finite-Lived Intangible Assets, Net [Abstract]
Gross Amount	$ 673		$ 613
Accumulated Amortization	(260)		(209)
Net Carrying Amount	413		404
Amortization [Abstract]
Amortization of Intangible Assets	61	$ 66
Annual amortization expense for intangible assets [Abstract]
Remainder of 2024	21
2025	63
2026	53
2027	49
2028	47
Product and process technology
Finite-Lived Intangible Assets, Net [Abstract]
Gross Amount	662		613
Accumulated Amortization	(260)		(209)
Net Carrying Amount	402		404
Increase in product and process technology	$ 60	$ 72
Product and process technology \| Weighted Average
Finite-Lived Intangible Assets, Net [Abstract]
Useful lives of assets placed into service	10 years	9 years
Other
Finite-Lived Intangible Assets, Net [Abstract]
Gross Amount	$ 11		0
Accumulated Amortization	0		0
Net Carrying Amount	$ 11		$ 0

Leases - Cost and Cash Flows (D

Leases - Cost and Cash Flows (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023	Aug. 31, 2023
Components of Lease Expense
Amortization of right-of-use asset		$ 52	$ 28	$ 121	$ 77
Interest on lease liability		18	6	48	18
Operating lease cost(1)	[1]	35	34	103	101
Total lease cost		$ 105	$ 68	272	196
Cash flows used for operating activities
Finance leases				41	17
Operating leases				98	91
Cash flows used for financing activities
Cash flows used for financing activities – Finance leases				99	79
Finance leases, noncash acquisitions of right-of-use assets				758	354
Operating leases, noncash acquisitions of right-of-use assets				$ 48	$ 35
Lessee, Finance Lease Description
Finance Lease Right-of-Use Asset, Balance Sheet Location		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Finance lease right-of-use assets (included in property, plant, and equipment)		$ 1,944		$ 1,944		$ 1,311
Finance leases, Weighted-average remaining lease term (in years)		8 years		8 years		9 years
Finance leases, Weighted-average discount rate		4.78%		4.78%		3.86%
Lessee, Operating Lease Description
Operating Lease Liability, Balance Sheet Location		Accounts payable and accrued expenses		Accounts payable and accrued expenses		Accounts payable and accrued expenses
Current operating lease liabilities (included in accounts payable and accrued expenses)		$ 68		$ 68		$ 66
Operating leases, Weighted-average remaining lease term (in years)		10 years		10 years		11 years
Operating leases, Weighted-average discount rate		3.37%		3.37%		3.21%

[1] Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented.

Leases - Maturities (Details)

Leases - Maturities (Details) - USD ($) $ in Millions	May 30, 2024	Aug. 31, 2023
Finance Lease Maturities
Remainder of 2024	$ 95
2025	368
2026	351
2027	341
2028	328
2029 and thereafter	778
Less imputed interest	(335)
Total Finance Lease Obligations	1,926	$ 1,281
Operating Lease Maturities
Remainder of 2024	9
2025	86
2026	88
2027	86
2028	80
2029 and thereafter	468
Less imputed interest	(140)
Operating Lease Liability	$ 677

Leases - Not Yet Commenced (Det

Leases - Not Yet Commenced (Details) $ in Millions	May 30, 2024 USD ($)
Finance Lease Not yet Commenced
Payment obligations	$ 704
Weighted Average
Finance Lease Not yet Commenced
Lease term	14 years

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	May 30, 2024	Aug. 31, 2023
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts payable	$ 1,951	$ 1,725
Property, plant, and equipment	1,663	1,419
Salaries, wages, and benefits	909	367
Income and other taxes	121	67
Other	501	380
Total accounts payable and accrued expenses	$ 5,145	$ 3,958

Debt - Long-term Debt (Details)

Debt - Long-term Debt (Details) - USD ($) $ in Millions		May 30, 2024	Jan. 12, 2024	Aug. 31, 2023
Long-term Debt by Current and Noncurrent
Total Long-term Debt		$ 11,332
Finance Lease Effective Rate (in ten thousandths)		4.78%		3.86%
Current Finance Lease Obligations		$ 292		$ 172
Long-Term Finance Lease Obligations		1,634		1,109
Total Finance Lease Obligations		1,926		1,281
Long-term Debt and Lease Obligation
Current debt (including finance lease obligation)		398		278
Long-term debt (including finance lease obligation)		12,860		13,052
Total Net Carrying Amount of Debt (including finance lease obligation)		$ 13,258		$ 13,330
Current finance lease liability, statement of financial position		Current debt (including finance lease obligation)		Current debt (including finance lease obligation)
Noncurrent finance lease liability, statement of financial position		Long-term debt (including finance lease obligation)		Long-term debt (including finance lease obligation)
Interest rate swap \| Fair value hedges \| Designated hedging instruments
Long-term Debt and Lease Obligation
Notional or Contractual Amount		$ 900		$ 900
SOFR \| Interest rate swap \| Fair value hedges \| Designated hedging instruments
Long-term Debt and Lease Obligation
Spread on 2027 Variable Interest Rate		3.33%
Term Loan \| 2026 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		6.791%
Effective Rate (in ten thousandths)		6.93%
Current Portion of Long-term Debt		$ 49		49
Noncurrent Long-Term Debt		884		921
Total Long-term Debt		$ 933		970
Term Loan \| 2027 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		6.916%
Effective Rate (in ten thousandths)		7.05%
Current Portion of Long-term Debt		$ 57		57
Noncurrent Long-Term Debt		1,021		1,063
Total Long-term Debt		1,078		1,120
Term Loan \| 2024 Term Loan A
Long-term Debt by Current and Noncurrent
Current Portion of Long-term Debt		0		0
Noncurrent Long-Term Debt		0		587
Total Long-term Debt		0		587
Term Loan \| 2025 Term Loan A
Long-term Debt by Current and Noncurrent
Current Portion of Long-term Debt		0		0
Noncurrent Long-Term Debt		0		1,050
Total Long-term Debt		$ 0		1,050
Corporate Bonds \| 2026 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		4.975%
Effective Rate (in ten thousandths)		5.07%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		499		499
Total Long-term Debt		$ 499		499
Corporate Bonds \| 2027 Notes(1)
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)	[1]	4.185%
Effective Rate (in ten thousandths)	[1]	4.27%
Current Portion of Long-term Debt	[1]	$ 0		0
Noncurrent Long-Term Debt	[1]	800		798
Total Long-term Debt	[1]	$ 800		798
Corporate Bonds \| 2028 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.375%
Effective Rate (in ten thousandths)		5.52%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		597		596
Total Long-term Debt		$ 597		596
Corporate Bonds \| 2029 A Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.327%
Effective Rate (in ten thousandths)		5.40%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		698		697
Total Long-term Debt		$ 698		697
Corporate Bonds \| 2029 B Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		6.75%
Effective Rate (in ten thousandths)		6.54%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		1,262		1,263
Total Long-term Debt		$ 1,262		1,263
Corporate Bonds \| 2030 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		4.663%
Effective Rate (in ten thousandths)		4.73%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		847		846
Total Long-term Debt		$ 847		846
Corporate Bonds \| 2031 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.30%	5.30%
Effective Rate (in ten thousandths)		5.41%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		994		0
Total Long-term Debt		$ 994		0
Corporate Bonds \| 2032 Green Bonds
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		2.703%
Effective Rate (in ten thousandths)		2.77%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		995		995
Total Long-term Debt		$ 995		995
Corporate Bonds \| 2033 A Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.875%
Effective Rate (in ten thousandths)		5.96%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		745		745
Total Long-term Debt		$ 745		745
Corporate Bonds \| 2033 B Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.875%
Effective Rate (in ten thousandths)		6.01%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		891		890
Total Long-term Debt		$ 891		890
Corporate Bonds \| 2041 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		3.366%
Effective Rate (in ten thousandths)		3.41%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		497		497
Total Long-term Debt		$ 497		497
Corporate Bonds \| 2051 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		3.477%
Effective Rate (in ten thousandths)		3.52%
Current Portion of Long-term Debt		$ 0		0
Noncurrent Long-Term Debt		496		496
Total Long-term Debt		$ 496		$ 496

[1] In 2021, we entered into fixed-to-floating interest rate swaps on the 2027 Notes with an aggregate $900 million notional amount equal to the principal amount of the 2027 Notes. The resulting variable interest paid is at a rate equal to SOFR plus approximately 3.33%. The fixed-to-floating interest rate swaps are accounted for as fair value hedges, and as a result, the carrying values of our 2027 Notes reflect adjustments in fair value.

Debt - Debt Activity and 2031 N

Debt - Debt Activity and 2031 Notes (Details) - USD ($)			9 Months Ended
Debt - Debt Activity and 2031 Notes (Details) - USD ($)	May 29, 2024	Jan. 12, 2024	May 30, 2024
Debt Activity
Increase (Decrease) in Principal			$ (640,000,000)
Increase (Decrease) in Carrying Value			(644,000,000)
Increase (Decrease) in Cash From Certain Debt Activities, Net			(647,000,000)
2031 Notes
Debt Instrument, Unamortized Discount Debt Issuance Costs			$ 34,000,000
2031 Notes \| Corporate Bonds
Debt Activity
Increase (Decrease) in Principal		$ 1,000,000,000
Increase (Decrease) in Carrying Value		993,000,000
Increase in Cash - Issuance		993,000,000
2031 Notes
Debt Instrument, Face Amount		$ 1,000,000,000
Debt Instrument, Interest Rate, Stated Percentage		5.30%	5.30%
Debt Instrument, Unamortized Discount Debt Issuance Costs		$ 7,000,000
Redemption Price Percentage (in hundredths)		100%
Debt Covenant, Restricted Subsidiaries, Ownership Percentage by Parent (in hundredths)		80%
Debt Instrument, Redemption Price Percentage, Change in Control Event (in hundredths)		101%
Debt Instrument, Covenant Description			The 2031 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock and which own principal property, as defined in the indenture governing the 2031 Notes) to (1) create or incur certain liens; (2) enter into certain sale and lease-back transactions; and (3) consolidate with or merge with or into, or convey, transfer, or lease all or substantially all of our properties and assets, to another entity. These covenants are subject to a number of limitations and exceptions. Additionally, if a change of control triggering event occurs, as defined in the indenture governing the 2031 Notes, we will be required to offer to purchase the 2031 Notes at 101% of the outstanding aggregate principal amount plus accrued interest up to the purchase date.
2024 Term Loan A \| Term Loan
Debt Activity
Increase (Decrease) in Principal		$ (588,000,000)
Increase (Decrease) in Carrying Value		(587,000,000)
(Decrease) in Cash - Prepayments		(588,000,000)
2025 Term Loan A \| Term Loan
Debt Activity
Increase (Decrease) in Principal	$ (650,000,000)	(402,000,000)
Increase (Decrease) in Carrying Value	(649,000,000)	(401,000,000)
(Decrease) in Cash - Prepayments	$ (650,000,000)	$ (402,000,000)

Debt - Revolving Credit Facilit

Debt - Revolving Credit Facility (Details)	9 Months Ended
Debt - Revolving Credit Facility (Details)	May 30, 2024 USD ($) Rate
Revolving Credit Facility
Total Long-term Debt	$ 11,332,000,000
Revolving Credit Facility \| 2026 Revolving Credit Facility
Revolving Credit Facility
Total Long-term Debt	0
Available Borrowing Capacity	$ 2,500,000,000
Debt Covenants
[Original] Debt Covenant, Ratio Of Total Debt To Adjusted EBITDA \| Rate	325%
[Temp Amendment] Debt Instrument, Covenant, Ratio Of Net Debt To Adjusted EBITDA \| Rate	325%
[Temp Amendment] Debt Instrument, Covenant, Minimum Liquidity	$ 5,000,000,000
[Original and Temp Amendment] Debt Instrument, Covenant, Ratio of Total Debt To Adjusted EBITDA, Temporary Increase \| Rate	375%
Debt Instrument, Covenant Description	The Revolving Credit Facility requires us to maintain, on a consolidated basis, a leverage ratio of total indebtedness to adjusted EBITDA, as defined in the Revolving Credit Facility and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00. On March 27, 2023, we amended the Revolving Credit Facility to provide that in lieu of the foregoing leverage ratio, during the fourth quarter of 2023 and each quarter of 2024, we will be required to maintain, on a consolidated basis, a net leverage ratio of total net indebtedness to adjusted EBITDA, as defined in the Revolving Credit Facility and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00. Alternatively, for up to three of such five quarters, we may elect to comply with a requirement of minimum liquidity, as defined in the Revolving Credit Facility, of not less than $5.0 billion. Each of the leverage ratio and net leverage ratio maximums, as applicable, is subject to a temporary four quarter increase in such ratio to 3.75 to 1.00 following certain material acquisitions. Through the third quarter of 2024, we complied with these requirements under the Revolving Credit Facility.
Revolving Credit Facility \| 2026 Revolving Credit Facility \| Minimum \| Adjusted term SOFR
Revolving Credit Facility
Debt Instrument, Basis Spread on Variable Rate	1%
Revolving Credit Facility \| 2026 Revolving Credit Facility \| Minimum \| SOFR
Revolving Credit Facility
Debt Instrument, Basis Spread on Variable Rate	0.11%
Revolving Credit Facility \| 2026 Revolving Credit Facility \| Maximum \| Adjusted term SOFR
Revolving Credit Facility
Debt Instrument, Basis Spread on Variable Rate	1.75%
Revolving Credit Facility \| 2026 Revolving Credit Facility \| Maximum \| SOFR
Revolving Credit Facility
Debt Instrument, Basis Spread on Variable Rate	0.43%

Debt - Maturities of Notes Paya

Debt - Maturities of Notes Payable (Details) $ in Millions	May 30, 2024 USD ($)
Maturities of Notes Payable
Remainder of 2024	$ 27
2025	107
2026	607
2027	1,780
2028	1,493
2029 and thereafter	7,450
Unamortized issuance costs, discounts, and premium, net	(34)
Hedge accounting fair value adjustment	(98)
Total Long-term Debt	$ 11,332

Contingencies (Details)

Contingencies (Details) $ in Millions			9 Months Ended
Contingencies (Details) $ in Millions	Jun. 04, 2024 patent	Jun. 03, 2024 patent	May 30, 2024 USD ($) patent
Netlist Inc. vs Micron \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Netlist Inc vs Micron - Complaint 2 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			3
Netlist Inc. vs Micron - Complaint 3 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2
Netlist Inc. vs Micron - Complaint 4 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			6
Netlist Inc. vs Micron - Complaint 5 \| Patent Matters
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Netlist Inc. vs Micron - Complaint 5 Amendment \| Patent Matters \| Expecting Appeal
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2
Number of patents found infringed (jury)			2
Netlist Inc. vs Micron - Complaint 5 Amendment \| Patent 7,619,912
Loss Contingencies [Line Items]
Number of patents found unpatentable by US Patent and Trademark Office			1
Netlist Inc. vs Micron - Complaint 5 Amendment \| Patent 7,619,912 \| Expecting Appeal
Loss Contingencies [Line Items]
Damages awarded to Netlist \| $			$ 425
Netlist Inc. vs Micron - Complaint 5 Amendment \| Patent 11,093,417 \| Expecting Appeal
Loss Contingencies [Line Items]
Damages awarded to Netlist \| $			$ 20
Sonrai Memory, Ltd. vs Micron \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2
Besang, Inc. \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Yangtze Memory Technologies Company, Ltd. vs Micron \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			8
Yangtze Memory Technologies Company, Ltd. vs. Micron Complaint 2 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			3
MimirIP Complaint vs Micron \| Patent Matters \| Pending Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed		6
MimirIP vs Micron Complaint 2 \| Patent Matters \| Pending Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed		6
MimirIP vs Micron Complaint 3 \| Patent Matters \| Pending Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed	6

Equity - Common Stock Repurchas

Equity - Common Stock Repurchases and Dividends (Details) - USD ($)		3 Months Ended						9 Months Ended		69 Months Ended
	Jun. 26, 2024	May 30, 2024	Feb. 29, 2024	Nov. 30, 2023	Jun. 01, 2023	Mar. 02, 2023	Dec. 01, 2022	May 30, 2024	Jun. 01, 2023	May 30, 2024
Common Stock Repurchases
Payments for Repurchase of Common Stock								$ 0	$ 425,000,000
Dividends
Payments of Common Stock Dividends		$ 128,000,000	$ 127,000,000	$ 129,000,000				384,000,000	$ 378,000,000
Payments of Common Stock Dividends (per share)		$ 0.115	$ 0.115	$ 0.115
Cash dividends declared (per share)		$ 0.115	$ 0.115	$ 0.115	$ 0.115	$ 0.115	$ 0.115
Subsequent Event
Dividends
Cash dividends declared (per share)	$ 0.115
Dividends Payable, Date to be Paid	Jul. 23, 2024
Dividends Payable, Date of Record	Jul. 08, 2024
Repurchases Authorized by the BOD
Common Stock Repurchases
Common Stock Repurchase, Authorized Amount		$ 10,000,000,000						$ 10,000,000,000		$ 10,000,000,000
Treasury Shares Repurchased (in shares)								0
Payments for Repurchase of Common Stock										$ 6,890,000,000

Equity - Accumulated Other Comp

Equity - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	May 30, 2024	Feb. 29, 2024	Nov. 30, 2023	Jun. 01, 2023	Mar. 02, 2023	Dec. 01, 2022	May 30, 2024	Jun. 01, 2023
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)			$ (312)				$ (312)
Other comprehensive income (loss) before reclassifications							(135)
Amount reclassified out of accumulated other comprehensive income (loss)							136
Tax effects							0
Other comprehensive income (loss)	$ (47)	$ (4)	52	$ 33	$ 100	$ 87	1	$ 220
Accumulated other comprehensive income (loss)	(311)						(311)
Gains (Losses) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)			(304)				(304)
Other comprehensive income (loss) before reclassifications							(151)
Amount reclassified out of accumulated other comprehensive income (loss)							139
Tax effects							(2)
Other comprehensive income (loss)							(14)
Accumulated other comprehensive income (loss)	(318)						(318)
Unrealized Gains (Losses) on Investments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)			(41)				(41)
Other comprehensive income (loss) before reclassifications							16
Amount reclassified out of accumulated other comprehensive income (loss)							0
Tax effects							1
Other comprehensive income (loss)							17
Accumulated other comprehensive income (loss)	(24)						(24)
Pension Liability Adjustments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)			36				36
Other comprehensive income (loss) before reclassifications							0
Amount reclassified out of accumulated other comprehensive income (loss)							(3)
Tax effects							1
Other comprehensive income (loss)							(2)
Accumulated other comprehensive income (loss)	34						34
Cumulative Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)			$ (3)				(3)
Other comprehensive income (loss) before reclassifications							0
Amount reclassified out of accumulated other comprehensive income (loss)							0
Tax effects							0
Other comprehensive income (loss)							0
Accumulated other comprehensive income (loss)	$ (3)						$ (3)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	May 30, 2024	Aug. 31, 2023
Fair Value
Fair Value of Notes Payable
Notes (level 2)	$ 11,037	$ 11,549
Carrying Value
Fair Value of Notes Payable
Notes (level 2)	$ 11,332	$ 12,049

Derivative Instruments - Notion

Derivative Instruments - Notional Amounts and Fair Values (Details) - USD ($) $ in Millions		9 Months Ended
		May 30, 2024	Aug. 31, 2023
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	$ 31	$ 63
Fair Value of Liabilities	[2]	$ (348)	(297)
Designated hedging instruments \| Cash flow hedges
Fair Value of Derivative Assets and Liabilities
General maturity of cash flow hedges (in years)		2 years
Designated hedging instruments \| Cash flow hedges \| Currency hedges
Notional Disclosures
Notional or Contractual Amount		$ 4,177	3,873
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	2	16
Fair Value of Liabilities	[2]	(234)	(180)
Designated hedging instruments \| Cash flow hedges \| Commodity hedges
Notional Disclosures
Notional or Contractual Amount		458	331
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	25	45
Fair Value of Liabilities	[2]	(4)	0
Designated hedging instruments \| Fair value hedges \| Interest rate swap
Notional Disclosures
Notional or Contractual Amount		900	900
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	0	0
Fair Value of Liabilities	[2]	(98)	(100)
Not designated hedging instruments \| Currency hedges
Notional Disclosures
Notional or Contractual Amount		1,964	1,839
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	4	2
Fair Value of Liabilities	[2]	$ (12)	$ (17)
General maturity of currency forward contracts (in months)		3 months

[1] Included in receivables and other noncurrent assets. Included in accounts payable and accrued expenses and other noncurrent liabilities.

Derivative Instruments - Gain (

Derivative Instruments - Gain (Loss) on Derivatives (Details) - Designated hedging instruments - Cash flow hedges - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023
Cash Flow Hedges
Net gains (losses) recognized in other comprehensive income (loss) from cash flow hedges	$ (99)	$ (40)	$ (142)	$ 88
Gain (loss) from components excluded from cash flow hedge effectiveness	(35)	(26)	(105)	(71)
Reclassifications from other comprehensive income (loss) to earnings	$ (39)	$ (77)	(139)	$ (199)
Cash flow hedge (losses) expected to be reclassified into earnings within twelve months			$ (168)

Equity Plans - Restricted Stock

Equity Plans - Restricted Stock Awards and ESPP (Details) - $ / shares shares in Millions	3 Months Ended		9 Months Ended
	Feb. 29, 2024	Mar. 02, 2023	May 30, 2024	Jun. 01, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)			72
Restricted Stock Awards
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Restricted stock award shares granted (in shares)			12	14
Weighted-average grant date fair value per share (in dollars per share)			$ 69.02	$ 54.13
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)			12
Employee Stock Purchase Plan ("ESPP")
ESPP Offering Period	6 months	6 months
ESPP shares purchased (in shares)	2	3
ESPP weighted average price of shares purchased	$ 60.68	$ 52.45

Equity Plans - Stock-based Comp

Equity Plans - Stock-based Compensation Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023	Aug. 31, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 217	$ 148	$ 608	$ 407
Equity Plans, Additional Disclosures
Total unrecognized compensation costs related to non-vested awards expected to be recognized	1,510		$ 1,510
Weighted average period that unrecognized compensation costs is expected to be recognized (in years)			1 year 3 months 18 days
Equity plans
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Expense capitalized and remained in inventory	100		$ 100		$ 88
Restricted Stock Awards
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	201	129	555	354
Employee Stock Purchase Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	16	19	53	53
Cost of goods sold
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	80	61	227	137
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	77	57	222	169
Selling, general, and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	60	34	159	107
Restructure
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 0	$ (4)	$ 0	$ (6)

Revenue and Customer Contract_3

Revenue and Customer Contract Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023	Aug. 31, 2023
Disaggregation of Revenue [Line Items]
Revenue	$ 6,811	$ 3,752	$ 17,361	$ 11,530
Total contract liabilities	756		756
Current customer contract liabilities	615		615
Estimated consideration payable to customers for pricing adjustments and returns	617		617		$ 453
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-05-30
Disaggregation of Revenue [Line Items]
Future performance obligation beyond one year	$ 141		$ 141
Expected timing of satisfaction of future performance obligation
DRAM
Disaggregation of Revenue [Line Items]
Revenue	$ 4,692	2,672	$ 12,277	8,223
NAND
Disaggregation of Revenue [Line Items]
Revenue	2,065	1,013	4,862	3,001
Other (primarily NOR)
Disaggregation of Revenue [Line Items]
Revenue	$ 54	$ 67	$ 222	$ 306

Restructure and Asset Impairm_3

Restructure and Asset Impairments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Employee severance	$ 0	$ 70	$ 0	$ 163
Asset impairments and other asset-related costs	0	1	0	9
Other	0	(3)	0	(5)
Restructure and asset impairments	$ 0	$ 68	$ 0	$ 167
Restructure headcount reduction (in hundredths)					15%

Other Operating (Income) Expe_3

Other Operating (Income) Expense, Net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023
Other Income and Expenses [Abstract]
(Gain) loss on disposition of property, plant, and equipment	$ (38)	$ (24)	$ (63)	$ (46)
Patent cross-license agreement gain	0	0	(200)	0
Litigation settlement	0	68	0	68
Other	10	4	(4)	7
Other operating (income) expense, net	$ (28)	$ 48	$ (267)	$ 29

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	May 30, 2024	Jun. 01, 2023	May 30, 2024	Jun. 01, 2023
Income Tax Disclosure [Abstract]
Income (loss) before taxes	$ 715	$ (1,753)	$ (270)	$ (4,200)
Income tax (provision) benefit	$ (377)	$ (139)	$ 172	$ (201)
Effective tax rate	52.70%	(7.90%)	63.70%	(4.80%)
Other Income Tax Assets, Current	$ 539		$ 539

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended						9 Months Ended
	May 30, 2024	Feb. 29, 2024	Nov. 30, 2023	Jun. 01, 2023	Mar. 02, 2023	Dec. 01, 2022	May 30, 2024	Jun. 01, 2023
Earnings Per Share Reconciliation
Net income (loss) - Basic	$ 332	$ 793	$ (1,234)	$ (1,896)	$ (2,312)	$ (195)	$ (109)	$ (4,403)
Net income (loss) - Diluted	$ 332			$ (1,896)			$ (109)	$ (4,403)
Weighted Average Number of Shares Outstanding Reconciliation
Weighted-average common shares outstanding – Basic	1,107			1,094			1,104	1,092
Dilutive effect of equity plans	16			0			0	0
Weighted-average common shares outstanding – Diluted	1,123			1,094			1,104	1,092
Basic (in dollars per share)	$ 0.30			$ (1.73)			$ (0.10)	$ (4.03)
Diluted (in dollars per share)	$ 0.30			$ (1.73)			$ (0.10)	$ (4.03)
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	1			31			31	33

Segment and Other Information_2

Segment and Other Information (Details) $ in Millions	3 Months Ended		9 Months Ended
Segment and Other Information (Details) $ in Millions	May 30, 2024 USD ($)	Jun. 01, 2023 USD ($)	May 30, 2024 USD ($) segment	Jun. 01, 2023 USD ($)
Reportable Segments
Number of reportable segments \| segment			4
Net sales
Revenue	$ 6,811	$ 3,752	$ 17,361	$ 11,530
Operating income (loss)
Operating income (loss)	719	(1,761)	(218)	(4,273)
Unallocated
Stock-based compensation	(217)	(148)	(608)	(407)
Restructure and asset impairments	0	(68)	0	(167)
Provision to write-down inventories to net realizable value			0	(1,831)
Patent cross-license agreement gain	0	0	200	0
Litigation settlement	0	(68)	0	(68)
Operating Segments
Operating income (loss)
Operating income (loss)	941	(1,349)	(797)	(2,061)
Unallocated
Operating income (loss)
Operating income (loss)	(222)	(412)	579	(2,212)
Unallocated
Stock-based compensation	(217)	(151)	(608)	(413)
Restructure and asset impairments	0	(68)	0	(167)
Provision to write-down inventories to net realizable value	0	(401)	0	(1,831)
Lower costs from sale of inventory written down in prior periods	0	281	987	281
Patent cross-license agreement gain	0	0	200	0
Litigation settlement	0	(68)	0	(68)
Other	(5)	(5)	0	(14)
CNBU
Net sales
Revenue	2,573	1,389	6,495	4,510
CNBU \| Operating Segments
Operating income (loss)
Operating income (loss)	442	(337)	73	(182)
MBU
Net sales
Revenue	1,588	819	4,479	2,419
MBU \| Operating Segments
Operating income (loss)
Operating income (loss)	301	(478)	(395)	(1,017)
EBU
Net sales
Revenue	1,294	912	3,442	2,777
EBU \| Operating Segments
Operating income (loss)
Operating income (loss)	124	65	133	347
SBU
Net sales
Revenue	1,353	627	2,911	1,814
SBU \| Operating Segments
Operating income (loss)
Operating income (loss)	76	(601)	(631)	(1,215)
All Other
Net sales
Revenue	3	5	34	10
All Other \| Operating Segments
Operating income (loss)
Operating income (loss)	$ (2)	$ 2	$ 23	$ 6

Certain Concentrations (Details

Certain Concentrations (Details) - Revenue from Contract with Customer	9 Months Ended
	May 30, 2024	Jun. 01, 2023
Product Concentration Risk \| Mobile
Concentration Risk [Line Items]
Concentration Risk, Percentage	25%	20%
Product Concentration Risk \| Automotive, industrial, and consumer
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%	25%
Product Concentration Risk \| Enterprise and cloud server
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%	20%
Product Concentration Risk \| Client and graphics
Concentration Risk [Line Items]
Concentration Risk, Percentage	15%	20%
Product Concentration Risk \| SSDs and other storage
Concentration Risk [Line Items]
Concentration Risk, Percentage	15%	15%
Customer Concentration Risk \| Undisclosed Customer
Concentration Risk [Line Items]
Concentration Risk, Percentage	11%